---
$id: https://graph.org.ai/products/commodity/51401504
$type: Product
source: UNSPSC
code: "51401504"
title: "Cinolazepam"
class: "51401500"
classTitle: "Tranquilizers and antimanic and antianxiety benzodiazepines"
family: "51400000"
familyTitle: "Tranquilizers and antimanic and antianxiety drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Cinolazepam

**UNSPSC Code**: 51401504
**Class**: [Tranquilizers and antimanic and antianxiety benzodiazepines](Tranquilizers and antimanic and antianxiety benzodiazepines.mdx)
**Family**: [Tranquilizers and antimanic and antianxiety drugs](../Tranquilizers and antimanic and antianxiety drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a benzodiazepine with the molecular formula C18H13ClFN3O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 68P0556B0U, chemically known as 7-chloro-5-(o-fluorophenyl)-2,3-dihydro-3-hydroxy-2-oxo-1h-1,4-benzodiazepine-1-propionitrile but generally known as cinolazepam, which bears US NIH Compound Identifier 3033621. European Medicines Agency schedules Cinolazepam in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06307MIG. The term CINOLAZEPAM is an International Non-Proprietary Name. World Health Organization schedules cinolazepam in its Anatomical Therapeutic Chemical (ATC) Classification. CINOLAZEPAM is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule cinolazepam under HS 29339940 and SITC 51577. As of Q4 2014, CINOLAZEPAM remains the US FDA Preferred Term for this commodity. Cinolazepam bears US NLM identifiers UMLS ID C0164835 and NCI Concept Code C77635. SMILES: CLC1CC2C(N(CCC#N)C(=O)C(O)N=C2C2C(F)CCCC2)CC1.

